Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2022-01-18 06:15 am Sale | 13G | GYRE THERAPEUTICS INC GYRE | Assenagon Asset Management S.A. | 0 0.000% | -1,876,898 (Position Closed) | View |
| 2022-01-18 06:12 am Purchase | 13G | GYRE THERAPEUTICS INC GYRE | Assenagon Asset Management S.A. | 1,876,898 5.980% | 762,294 (+68.39%) | View |
| 2021-11-24 09:13 am Sale | 13G | MINERVA NEUROSCIENCES INC NERV | Assenagon Asset Management S.A. | 1,385,491 3.240% | -4,695,821 (-77.22%) | View |
| 2021-11-24 09:11 am Purchase | 13G | MINERVA NEUROSCIENCES INC NERV | Assenagon Asset Management S.A. | 6,081,312 14.230% | 6,081,312 (New Position) | View |
| 2020-08-06 11:13 am Purchase | 13G | GYRE THERAPEUTICS INC GYRE | Assenagon Asset Management S.A. | 1,114,604 6.390% | 878,853 (+372.79%) | View |
| 2020-08-06 11:13 am Unchanged | 13G | GYRE THERAPEUTICS INC GYRE | Assenagon Asset Management S.A. | 235,751 1.070% | 0 (Unchanged) | View |
| 2020-08-04 11:27 am Sale | 13G | IMPINJ INC PI | Assenagon Asset Management S.A. | 413,869 1.810% | -762,338 (-64.81%) | View |
| 2020-08-04 08:48 am Purchase | 13G | IMPINJ INC PI | Assenagon Asset Management S.A. | 1,176,207 5.150% | 527,411 (+81.29%) | View |
| 2020-06-24 12:25 pm Sale | 13G | LendingClub Corp LC | Assenagon Asset Management S.A. | 2,096,071 3.000% | -1,651,200 (-44.06%) | View |
| 2020-06-24 12:17 pm Purchase | 13G | LendingClub Corp LC | Assenagon Asset Management S.A. | 3,747,271 5.360% | 3,747,271 (New Position) | View |
| 2020-06-19 10:20 am Sale | 13G | CATALYST BIOSCIENCES INC N CBIO | Assenagon Asset Management S.A. | 235,751 1.070% | -878,853 (-78.85%) | View |
| 2020-06-19 10:18 am Purchase | 13G | CATALYST BIOSCIENCES INC N CBIO | Assenagon Asset Management S.A. | 1,114,604 6.390% | 1,114,604 (New Position) | View |
| 2020-06-17 11:54 am Unchanged | 13G | AFFIMED N V NE AFMD | Assenagon Asset Management S.A. | 779 1.020% | 0 (Unchanged) | View |
| 2020-06-16 10:59 am Sale | 13G | AFFIMED N V NE AFMD | Assenagon Asset Management S.A. | 779 1.020% | -4,979,339 (-99.98%) | View |
| 2020-06-16 10:55 am Purchase | 13G | AFFIMED N V NE AFMD | Assenagon Asset Management S.A. | 4,980,118 6.530% | 4,980,118 (New Position) | View |
| 2020-04-17 11:05 am Sale | 13G | MAGNACHIP SEMICONDUCTOR CORP N MX | Assenagon Asset Management S.A. | 765,661 2.200% | -1,627,391 (-68.00%) | View |
| 2020-04-17 09:16 am Purchase | 13G | MAGNACHIP SEMICONDUCTOR CORP N MX | Assenagon Asset Management S.A. | 2,393,052 6.880% | 2,393,052 (New Position) | View |